✦ LIBER ✦

Costs of First-Line Doublet Chemotherapy and Lifetime Medical Care in Advanced Non–small-Cell Lung Cancer in the United States

✍ Scribed by Kathleen Lang; Martin D. Marciniak; Douglas Faries; Michael Stokes; Don Buesching; Craig Earle; Joseph Treat; Steve Babineaux; Nathalie Morissette; David Thompson

Book ID: 109078928
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 127 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1111/j.1524-4733.2008.00472.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYFRA 21-1 as an early predictor of firs

CYFRA 21-1 as an early predictor of first line chemotherapy response in advanced non small cell lung cancer

✍ Kashif Iqbal; Yuan Chen; Mengxian Zhang; Qian Chu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 209 KB

Chemotherapy plus bevacizumab in the fir

Chemotherapy plus bevacizumab in the first-line treatment of non-small cell lung cancer: benefits, risks and limitations

✍ F. Grossi; A. Brianti; C. Defferrari; P. Pronzato 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 124 KB

Phase I study of second-line chemotherap

Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer

✍ Mikio Oka; Minoru Fukuda; Seiji Nagashima; Masaaki Fukuda; Akitoshi Kinoshita; H 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 84 KB

Comparative cost-minimisation of oral an

Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system

✍ K. Le Lay; E. Myon; S. Hill; L. Riou-Franca; D. Scott; M. Sidhu; D. Dunlop; R. L 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 170 KB

A phase II trial of gefitinib as mainten

A phase II trial of gefitinib as maintenance therapy after first-line chemotherapy for advanced non-small cell lung cancer in China

✍ Lu Yang; Zhi-jie Wang; Tong-tong An; Hua Bai; Jun Zhao; Jian-chun Duan; Ping-pin 📂 Article 📅 2010 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 283 KB

Influence of histological type, smoking

Influence of histological type, smoking history and chemotherapy on survival after first-line therapy in patients with advanced non-small cell lung cancer

✍ Toru Itaya; Nobuyuki Yamaoto; Masahiko Ando; Masako Ebisawa; Yukiko Nakamura; Ha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB